학술논문
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
Document Type
Article
Author
Source
In: Clinical Genitourinary Cancer . (Clinical Genitourinary Cancer, February 2021, 19(1):22-31.e5)
Subject
Language
English
ISSN
19380682
15587673
15587673